The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [<sup>177</sup>Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis

The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [<sup>177</sup>Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis

Background: The De Ritis ratio (aspartate aminotransferase [AST]/alanine aminotransferase [ALT]) has demonstrated prognostic value in various cancer entities. We evaluated the prognostic capability of the De Ritis ratio in patients with metastatic neuroendocrine tumors (NET) undergoing peptide recep...

Full description

Bibliographic Details
Main Authors: Tristan Ruhwedel, Julian M. M. Rogasch, Kai Huang, Henning Jann, Imke Schatka, Christian Furth, Holger Amthauer, Christoph Wetz
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
De Ritis ratio
NET
neuroendocrine tumor
CgA
Chromogranin A
AST
Online Access:https://www.mdpi.com/2072-6694/13/4/635

Internet

https://www.mdpi.com/2072-6694/13/4/635

Similar Items